Education
About Us
Working with TipRanks
Follow Us
Robert J Peach Insider Profile
4 Followers
Robert J Peach, Director at Amplia Therapeutics, holds 5.48M shares in Amplia Therapeutics (Ticker: INNMF), holds 1.45M shares in AdAlta Ltd. (Ticker: AU:1AD). Most recently, Robert J Peach Bought ― shares of Amplia Therapeutics on Dec 20, 2024 for an estimated value of 125.00K.
Profitable Transactions
3 out of 9 Profitable Transactions
Average Return
+30.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert J Peach holds in companies
Most Profitable Insider Trade
The most profitable trade made by Robert J Peach
Robert J Peach's Trading History
Amplia Therapeutics
Dec 20, 2024
Director
Informative Buy
125.00K
$1.15M
AdAlta Ltd.
Feb 11, 2022
Director
Informative Buy
11.47K
AU$14.53K
List of latest transactions for each holding click on a transaction to see Robert J Peach's performance on stock
You May Also Like
Robert J Peach insider profile FAQ
What is the percentage of profitable transactions made by Robert J Peach?
The percentage of profitable transactions made by Robert J Peach is 33%.
What is the average return per transaction made by Robert J Peach?
The average return per transaction made by Robert J Peach is 30.00%.
What stocks does Robert J Peach hold?
Robert J Peach holds: INNMF, AU:1AD stocks.
What was Robert J Peach’s latest transaction?
Robert J Peach latest transaction was an Informative Buy of $125.00K.
What was Robert J Peach's most profitable transaction?
Robert J Peach’s most profitable transaction was an Informative Buy of INNMF stock on December 20, 2024. The return on the trade was 283.30%.
What is Robert J Peach's role in Amplia Therapeutics?
Robert J Peach's role in Amplia Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.